Impact of the US Food and Drug Administration registration of antiretroviral drugs on global access to HIV treatment

Harinder Singh Chahal; Peter Capella; Ryan Presto; Jeffrey S Murray; Martin Shimer; Mary Lou Valdez; Peter G Lurie

doi:10.1136/bmjgh-2017-000651

Article info

PDF

XML

Research

Impact of the US Food and Drug Administration registration of antiretroviral drugs on global access to HIV treatment

Authors

Harinder Singh Chahal Office of Public Health Strategy and Analysis, Office of the Commissioner, US Food and Drug Administration, Silver Spring, MD, USA PubMed articles Google scholar articles
Peter Capella Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA PubMed articles Google scholar articles
Ryan Presto Office of Generic Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA PubMed articles Google scholar articles
Jeffrey S Murray Office of New Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA PubMed articles Google scholar articles
Martin Shimer Office of Generic Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA PubMed articles Google scholar articles
Mary Lou Valdez Office of International Programs, Office of the Commissioner, US Food and Drug Administration, Silver Spring, MD, USA PubMed articles Google scholar articles
Peter G Lurie Office of Public Health Strategy and Analysis, Office of the Commissioner, US Food and Drug Administration, Silver Spring, MD, USA PubMed articles Google scholar articles

Correspondence to Dr Harinder Singh Chahal, US Food and Drug Administration ; harinder.chahal{at}fda.hhs.gov

View Full Text

Citation

Chahal HS, Capella P, Presto R, et al

Impact of the US Food and Drug Administration registration of antiretroviral drugs on global access to HIV treatment

BMJ Global Health 2018;3:e000651.

Publication history

Received November 17, 2017
Revised February 28, 2018
Accepted March 1, 2018
First published May 17, 2018.

Online issue publication

May 01, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password